MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model

  • Authors:
    • Desheng Chen
    • Xianlong Zhang
    • Yongyuan Guo
    • Sifeng Shi
    • Xin Mao
    • Xiaoyun Pan
    • Tao Cheng
  • View Affiliations

  • Published online on: October 1, 2012     https://doi.org/10.3892/ijmm.2012.1145
  • Pages: 1417-1423
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Wear debris-induced osteolysis in periprosthetic tissue with aseptic loosening is a serious problem after total joint arthroplasty. Matrix metalloproteinase-9 (MMP-9) is expressed in osteoclast cells that surround loosening peri-implant tissue, but the molecular mechanism of MMP-9 action in wear debris-induced osteolysis remains ambiguous. We used a murine osteolysis model to examine the hypothesis that administration of an MMP-9 inhibitor reduces the expression of receptor activator of nuclear factor-κB (RANK) and nuclear factor-κB ligand (RANKL) and, thereby, suppressesdebris-induced inflammatory osteolysis. Experiments were performed in 3 groups of 15 mice: a control, a titanium (Ti) and a Ti plus tetracycline group. To provoke inflammatory osteolysis, calvarial bone was implanted from syngeneic littermates, followed by injection of Ti particles into established air pouches for all groups except the control. Tetracycline was administered daily by intraperitoneal (i.p.) injection, and PBS was administered by i.p. injection to the control and Ti groups. Mice were sacrificed 14 days after bone-Ti implantation. Pouch membranes with the intact bone implants were collected for histological and molecular analysis. Tetracycline had minimum effect on the expression of MMP-9 and tumor necrosis factor-α (TNF-α) but it decreased gene activation and inhibited the expression of RANK and RANKL, thereby inhibiting Ti-particle-induced inflammatory osteolysis. Tetracycline decreased the number of tartrate-resistant acid phosphatase (TRAP)-positive cells in the pouch tissues. Our results in the murine osteolysis model suggest that through the downregulation of RANK/RANKL, tetracycline significantly inhibits debris-induced inflammatory osteolysis. Its use in clinical practice may help prevent complications experienced by patients who have undergone total joint arthroplasty.

Introduction

Total joint arthroplasty is a cost-effective operative procedure for treating dysfunctional weight bearing joints, and relieves pain and restores joint function (1). However, aseptic loosening secondary to wear particle-associated osteolysis is an important cause of complication following hip and knee replacement surgery. Furthermore, revision surgery is associated with significant cost and potential morbidity (2,3).

Titanium (Ti) alloy particles are common wear debris particles in periprosthetic tissue. They stimulate the release and phagocytic activity of monocytes and macrophages around periprosthetic tissue and generate the release of a host of proinflammatory cytokines, including tumor necrosis factor-α (TNF-α), metalloproteinases (MMPs), interleukin-1β (IL-1β), interleukin-6 (IL-6), transforming growth factor-β (TGF-β), colony stimulating factor-1 (CSF-1) and macrophage-CSF (M-CSF) (4). The resulting inflammatory reaction is widely considered to play a key role in the formation of osteolysis induced by wear debris and finally results in aseptic loosening of the replaced joint (4).

The presence of wear particles from prosthetic implants may also trigger a histiocytic response at the synovial-like membrane which is present at the interface between the bone and the implant. This involves the activation and release of macrophages, fibroblasts, potential proinflammatory cytokines and MMPs, all of which promote bone absorption and osteolysis in periprosthetic tissue (5).

MMPs are a family of proteolytic enzymes that have been reported to be involved in the degradation of the extracellular matrix of various tissues such as bone and have been shown to induce bone resorption (6). MMP-1, -2, -3, -9, -10, -12 and -13 and membrane type 1 (MT-1)-MMP have all been implicated in osteolysis associated with aseptic loosening of joint prostheses (710). Matrix metalloproteinase-9 (MMP-9) is regarded as a gelatinase B, type IV collagenase and is highly expressed not only during the early stages of osteoclast development, but also in mature osteoclasts which resorb bone (11). Previous studies have demonstrated that MMP-9 activity has an important function in the pathogenesis of dental pulp inflammation (12). A high expression of MMP-9 has also been discovered in human osteoclastomas and osteoclasts in Paget’s disease (13). Activation of MMP-9 activity has been demonstrated to be restricted to macrophages in the pseudomembrane of the bone-implant interface (14). Therefore, it constitutes a potential drug target in this indication, and several studies have demonstrated that the inhibition of MMP-9 resulted in a reduced bone resorption in response to wear particles (15,16).

Other studies have demonstrated that the receptor activator of nuclear factor-κB ligand (RANKL) and the receptor activator of nuclear factor-κB (RANK) play an important role in regulating wear debris-induced osteoclastogenesis (17,18). Both TNF-α and IL-1β have been demonstrated to be regulated by the expression and activity of the RANK/RANKL in histiocytic tissue around loosened implants (19,20). However, the possible interaction between MMP-9 and RANK/RANKL signaling in the development of inflammatory osteolysis is not well characterized.

The present study using a murine osteolysis model was undertaken to examine the hypothesis that amelioration of Ti particle-induced inflammatory osteolysis by MMP-9 inhibition is mediated by the downregulation of RANK/RANKL, MMP-9 and TNF-α.

Materials and methods

Titanium alloy particles

Ti particles (diameter 0.1–20 μm) were obtained from Alfa Aesar Company (Fig. 1). The particles were washed 3 times in 70% ethanol solution to remove bound endotoxin and were sterilized in 10 mM phosphate-buffered saline (PBS) at pH 7.4. They were then suspended in sterile 10 mM PBS at a concentration of 15 mg/ml and stored at 4°C until needed. The suspension contained 5% (weight/volume) particles.

Murine osteolysis model

Female BALB/c mice, aged 8–10 weeks were purchased from the Shanghai Laboratory Animal Centre (Shanghai, China). The mice were randomly assigned to 3 experimental groups with 15 animals in each group: a control group (A), a Ti group (B) and a Ti plus tetracycline group (C).

All mice weighed 20–25 g at the start of the experiment. Previously described techniques were used to establish air pouches (21). Briefly, the dorsal area of each mouse (2×2 cm) was shaved and sterilized and 2 ml of sterile air was injected subcutaneously to establish an air pouch. To maintain the pouch, 0.5 ml of sterile air was injected into the pouch each day for 6 days.

After 6 days, mice with established air pouches were anaesthetized by i.p. injection of pentobarbital (50 mg/kg). A 0.5-cm incision overlying the pouch was performed and a section of calvarial bone (∼0.4×0.25 cm) from a genetically identical donor mouse was inserted into the pouch. The Ti alloy particle suspension (0.3 ml) was injected into established air pouches of the mice (except those from group A) to provoke inflammatory osteolysis. The pouch layers and the skin incision were then closed using 4-0 prolene sutures. Tetracycline 50 mg/kg was administered by i.p. injection to group C and 0.1 ml sterile PBS was administered by i.p. injection to groups A and B. Injections continued daily until the mice were sacrificed 14 days after bone-Ti implantation. Pouch membranes with the intact bone implants were harvested for histological and molecular analysis.

The Institutional Animal Care and Use Committee of the Shanghai Jiaotong University approved all animal procedures.

Histological evaluation

Tissue samples were fixed in 4% polyoxymethylene (pH 7.4) for 24 h, after decalcification in 10% ethylenediaminetetraacetic acid (EDTA). The specimens were processed for dehydration in graded alcohol, cleared in dimethyl benzene and embedded in paraffin. Tissue sections (6 μm) were stained with hematoxylin and eosin (H&E) to evaluate pouch membrane inflammation and implant bone erosion. The stained sections were examined under a light microscope (Olympus DP70; Olympus Optical Co., Tokyo, Japan) and digital photomicrographs were captured and analyzed using a computerized image analysis system with Image-Pro Plus software, version 6.0 (Media Cybernetics, Silver Spring, MD, USA). Pouch membrane thickness and the total numbers of infiltrated cells were measured using digital image analysis.

Four separate sections/specimen were analyzed in a blinded fashion. Pouch membrane thickness was measured at 6 points on each section and 6 random 100-μm longitudinal pouch areas were selected to count total cells (cells/mm2) based upon nucleus counts.

Expression of tartrate-resistant acid phosphatase (TRAP)

TRAP staining was used to identify the presence of osteoclast-like cells in the pouch tissue. Histochemical TRAP staining using a commercial kit (Sigma, St. Louis, MO, USA) was performed on pouches implanted with calvarium. Frozen sections (6 μm) were prepared and incubated in xylene for 30 sec and washed with ethanol. Sections were incubated at 37°C for 1 h in 100 mM acetate buffer (pH 5.2) containing 0.5 mM naphthol AS-BI phosphoric acid, 2.2 mM Fast Garnet GBC and 8 mM sodium tartrate. The sections were then washed in several changes of distilled water, followed by counterstaining with a hematoxylin solution. The presence of dark purple staining granules in the cytoplasm was determined as the specific criterion for TRAP-positive cells. Positive TRAP localization was quantified by pixel area count and reported as the percentage of the total implanted bone area in the pouch tissue.

Immunohistochemical staining for MMP-9, TNF-α, RANK and RANKL

Tissue sections were deparaffinized in xylene and rehydrated in ethanol. The rinsed sections were immersed in antigen retrieval buffer of EDTA in a water bath at 97°C for 30 min. The sections were allowed to cool to room temperature before preincubation for 10 min with 0.3% (vol/vol) hydrogen peroxide in methanol to suppress the activity of endogenous peroxidase. The sections were blocked with 1.5% normal goat serum for 30 min. They were then incubated at 4°C overnight with the primary antibodies: rabbit anti-MMP-9 (Abcam, USA), mouse anti-TNF-α, mouse anti-RANK-α and mouse anti-RANKL-α. The sections were rinsed and incubated for 30 min with biotin-conjugated secondary antibody (Sigma) at 37°C. Streptavidin-horseradish peroxidase conjugate (SA-HRP) was applied to sections for 30 min at 37°C. 3,3′-Diaminobenzidine tetrahydrochloride (DAB) was added for color development with counterstaining using hematoxylin. The digital photomicrographs were analyzed using the Image-Pro image analysis software package.

Gene expression of MMP-9, TNF-α, RANK and RANKL

Total RNA was extracted from pouch tissue using TRIzol reagent (Invitrogen Life Technologies, Carlsbad, CA, USA) according to the manufacturer’s instructions. cDNA was synthesized from the total RNA using a SYBR PrimeScript™ reverse transcription-polymerase chain reaction (RT-PCR) kit (Takara Bio, Inc., Shiga, Japan). Quantitative real-time RT-PCR was performed to evaluate the relative levels of mRNA for MMP-9, TNF-α, RANK and RANKL, using the SYBR PrimeScript™ RT-PCR kit and an ABI 7500 real-time thermal cycler (Applied Biosystems, Carlsbad, CA, USA) according to the manufacturer’s instructions. Gene specific primers for MMP-9, TNF-α, RANK and RANKL were designed using Primer 5.0 software (Premier Biosoft International, Palo Alto, CA, USA). The housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal control. The cycling program involved preliminary denaturation at 95°C for 2 min, followed by 40 cycles of denaturation at 95°C for 15 sec and annealing at 60°C for 1 min.

A comparative threshold cycle (Ct) method with arithmetic formulae was used to determine the relative level of gene expression following PCR amplification. Subtracting the Ct of the housekeeping gene from the Ct of the target gene yielded the ΔCt for each group (control and experimental groups) which was entered into the equation 2−ΔCt. The gene activity in the control group was arbitrarily assigned as 1 to serve as a reference. The primers used in this study were as shown in Table I.

Table I

Gene-specific primers for MMP-9, TNF-α, RANK, RANKL and GAPDH.

Table I

Gene-specific primers for MMP-9, TNF-α, RANK, RANKL and GAPDH.

GenesReverse primer sequenceForward primer sequenceSize (base pair)
MMP-9 5′-TACTGGAAGATGTCGTGTGAG-3′ 5′-GGCGTGTCTGGAGATTCG-3′112
TNF-α 5′-CAGGTCACTGTGTCCCAGCATCT-3′ 5′-GAGTCCGGGCAGGTCTACTTT-3′235
RANK 5′-GCGAGGTCTGGCTGACATAC-3′ 5′-CTGCCTCTGGGAACGTGACT-3′108
RANKL 5′-CTGCGTTTTCATGGAGTCTCA-3′ 5′-CAGCATCGCTCTGGTTCCTGTA-3′107
GAPDH 5′-TGCTGTTGAAGTCGCAGGAC-3′ 5′-CCAATGTGTCCGTCGTGGAT-3′153

[i] MMP-9, matrix metalloproteinase-9; TNF-α, tumor necrosis factor-α; RANK, receptor activator of nuclear factor-κB; RANKL, receptor activator of nuclear factor-κB ligand; GAPDH, glyceraldehyde-3-phosphate dehydrogenase.

Statistical analysis

Statistical analyses were carried out using the SPSS statistical package, version 11.0 (SPSS, Inc., Chicago, IL, USA). Values are expressed as mean ± standard deviation (SD). Differences between groups were analyzed using analysis of variance. Values of P<0.05 were considered statistically significant.

Results

Morphological appearance of H&E-stained sections

Air pouch thickness and cellular infiltration were assessed on H&E-stained sections (22). Biomaterial particles stimulate tissue inflammation, which is characterized by increased cellular infiltration and pouch membrane thickness (23). As shown in Fig. 2, membrane thickness and frequency of infiltrated cells were significantly increased in the Ti group compared with the control group (P<0.05). These effects were significantly alleviated by injection with tetracycline (P<0.05). Bone morphology remained intact in the control group (Fig. 2a), However, bone erosion was observed in pouches stimulated with Ti particles, particularly at the bone-membrane interface where erosion pits were observed (Fig. 2b). Exposure to tetracycline reduced the inflammatory osteolysis response in this murine osteolysis model (Fig. 2c).

Effect of tetracycline on MMP-9 expression

Staining for MMP-9 in the Ti plus tetracycline group was more intense compared to the control group, but less intense compared to the Ti group (Fig. 3a–c). Staining for MMP-9 was predominantly observed in the inflammatory cells surrounding the Ti particles.

Real-time RT-PCR assay indicated that MMP-9 gene transcription was significantly higher in the Ti plus tetracycline group compared to the control group (P<0.001) but was less marked compared to the Ti group. There was also a significant difference in the gene transcripts of MMP-9 between the Ti and Ti plus tetracycline groups (Fig. 3d). Real-time RT-PCR analysis also demonstrated that Ti particles stimulated a significant increase in the gene expression of inflammatory mediators in air pouch tissues, while tetracycline treatment significantly attenuated these responses.

Effect of tetracycline on TNF-α expression

Staining for TNF-α in the Ti group was significantly stronger compared to the control group (Fig. 4a–c). In the Ti plus tetracycline group there was evidence of significant suppression of the Ti particle-induced increase in TNF-α (P<0.05).

The gene levels of TNF-α determined by real-time RT PCR are displayed in Fig. 4d. The Ti particles significantly increased TNF-α gene expression compared to the control group (P<0.001). In addition, the number of gene copies of TNF-α was significantly reduced in the Ti plus tetracycline group (P<0.001).

Effect of tetracycline on RANK and RANKL expression

Immunohistochemical staining, as depicted in Figs. 5a–c and 6a–c, demonstrated increases in staining for both RANK and RANKL in the Ti group compared to the control group. RANKL staining was discovered at the interface between the pouch membranes and the implanted bone tissue and was significantly decreased in the tetracycline-treated group (P<0.05).

Real-time RT-PCR demonstrated that the Ti particles significantly (P<0.05) increased the expression of both RANK and RANKL gene transcripts in comparison with the control group (Figs. 5d and 6d). Exposure to tetracycline significantly reduced (P<0.001) the increases in RANK and RANKL gene transcripts compared with the Ti group.

Effect of tetracycline on Ti-particle-induced osteoclastogenesis

Paraffin sectioned calvaria-implanted pouches were stained to identify osteoclast-like cells. A typical TRAP-stained photomicrograph exhibiting an accumulation of dark purple TRAP-positive cells at the interface between the implanted calvaria and the pouch membrane is displayed in Fig. 7. Relatively few TRAP-positive cells were present in the control or Ti plus tetracycline groups.

Discussion

Wear debris-induced osteolysis and aseptic loosening is the most common complication of total joint replacement surgery (2). During the 10-year period following joint replacement, up to 20% of patients experience radiographic loosening of the joint (24). From the data available to date, persistent debris-induced inflammation and osteoclastogenesis may be critical factors involved in the etiology of aseptic implant loosening (25,26). Failed implants are often surrounded by a synovial membrane-like interface, known as the interfacial membrane, which plays a significant role in tissue destruction and causes characteristic chronic inflammation in the peri-implant area (27,28). The wear debris stimulus stimulates the gathering of fibroblasts, macrophages, and foreign body giant cells in interfacial membranes where they produce multiple proinflammatory cytokines such as TNF-α and IL-6 (29,30). In addition, the abundance of MMPs produced by these cells facilitates bone resorption around implants resulting in aseptic loosening (31).

MMP-9 is produced by multinucleated giant cells in response to wear debris at the interface membranes where it may facilitate orthoclastic bone resorption by degradation of extracellular matrix macromolecules present around and on the surface of the bone trabeculae (32). Previous studies have demonstrated that receptor activator of NF-κB (RANK) and RANK ligand (RANKL) are key factors that regulate bone turnover and are present in tissues near the site of peri-prosthetic osteolysis (18). However, whether MMP-9 acts as an upstream regulator of inflammation and bone resorption-induced RANK/RANKL signaling during inflammatory osteoclastogenesis remains ambiguous.

The present study was undertaken in a murine osteolysis model to examine the hypothesis that inhibition of Ti particle-induced inflammatory osteoclastogenesis by treatment with an MMP-9 inhibitor occurs through the downregulation of RANK/RANKL, MMP-9 and TNF-α. Immunohistochemistry and real-time RT-PCR for proinflammatory cytokines demonstrated that bone implantation and Ti particle stimulation of air pouches significantly increased protein and gene expression of MMP-9 and TNF-α, resulting in a significant inflammatory reaction (3335). We also demonstrated that TNF-α is produced in response to wear particles and that it affects downstream processes resulting in osteolysis (24,36). We used tetracycline, as a MMP-9 inhibitor on the basis that it has been observed to have a role in the treatment of several ophthalmologic diseases by affecting the expression of MMP-9 and TNF-α (37). Additionally, the tetracycline derivative, doxycycline, reduces MMP-9-mediated inflammation and the downstream effects of inflammation (16,38,39). This provides a potentially important therapeutic strategy for the management of debris-induced inflammation.

In our study, real-time RT-PCR displayed that the number of gene copies of MMP-9 was significantly reduced by exposure to tetracycline. In addition, immunohistochemical studies suggested that tetracycline impeded MMP-9 expression in Ti particle pouches. These findings suggest that tetracycline suppresses the activation and expression of MMP-9 in Ti particle-induced inflammatory osteolysis.

Data from our H&E-stained sections revealed that the presence of Ti particles increased cellular infiltration and pouch membrane thickness by stimulating tissue inflammation. However, membrane thickness and the frequency of cell infiltration were both significantly reduced in animals treated with tetracycline. In addition, we were able to identify TRAP-positive osteoclasts, by TRAP staining and discovered that tetracycline reduced the number of TRAP-positive cells in Ti particle-induced pouches. These findings suggest that tetracycline has the potential to decrease bone resorption in the murine air pouch osteolysis model.

The expression of both RANK and RANKL genes in our mouse model of peri-prosthesis tissue was well defined. Other studies have demonstrated that Ti particles significantly increased RANK/RANKL gene expression in murine pouch tissues (17,40) and it has been proposed that activation of the RANK/RANKL pathway may play a prominent role in the bone loss associated with aseptic loosening (40). In our study, tetracycline, an MMP-9 inhibitor, significantly reduced the expression of RANK and RANKL. MMP-9 has numerous effects on osteoclast and osteoblast function (4143), and previous research has demonstrated that wear debris increases the expression of MMP-9 and TNF-α, both in vivo and in vitro (44). These findings are consistent with our results.

TNF-α is considered to stimulate osteoclastogenesis through the upregulation of RANKL production in osteoblasts and through the stimulation of RANK expression in osteoclasts (45). This is in accordance with the observation that RANK and RANKL are downstream signaling molecules of the MMP-9 pathway. In our study, Ti particles increased the gene expression of RANK and RANKL in comparison with the control group, and tetracycline significantly decreased the expression of RANK and RANKL and reduced the number of TRAP-positive cells, compared with the control group. These findings suggest that tetracycline suppresses the expression of the RANK and RANKL signaling pathways in the presence of Ti particle-induced inflammatory osteolysis. However, a previous study demonstrated that RANKL signals through TRAF6 and that NFATc1 is a downstream effector of RANKL signaling to modulate MMP-9 gene expression during osteoclast differentiation (46). There may, therefore, be an interrelationship between MMP-9 and RANK/RANKL signaling in the development of inflammatory osteolysis, suggested by the fact that treatment with an MMP-9 inhibitor significantly reduced the levels of RANK/RANKL gene expression in the current study.

We used a murine model in this study, as it provides a sensitive and cost-effective way to investigate the responses of particle-induced inflammatory osteolysis in aseptic loosening and offers advantages over previously reported models (47). We used air pouches implanted with genetically identical donor mouse calvarial bone to gain insight into changes in bone resorption and to provide a model of chronic inflammation observed in inflammatory osteolysis. Collectively, our results of the murine osteolysis model suggest that MMP-9 plays a critical role in the process of wear debris-induced inflammatory osteolysis. MMP-9 inhibition by tetracycline impeded the expression of RANK/RANKL in the development of Ti-particle-induced inflammatory osteolysis, indicating that MMP-9 inhibition is a potential therapeutic target for the prevention of wear debris-induced inflammatory osteolysis. The optimal clinical protocol for tetracycline in this type of inflammation has yet to be determined through further research.

Acknowledgements

This study was supported by the Interdisciplinary (Engineering-Medical) Research Fund of Shanghai Jiao Tong University (grant no. YG2011MS30), the Shanghai Municipal Health Bureau Science Fund for Young Scholars (grant no. 2010QJ036A) and the National Natural Science Foundation of China (grant no. 81171688).

References

1. 

SM HorowitzSB DotyJM LaneAH BursteinStudies of the mechanism by which the mechanical failure of polymethylmethacrylate leads to bone resorptionJ Bone Joint Surg Am7580281319938314821

2. 

WH HarrisWear and periprosthetic osteolysis: the problemClin Orthop Relat Res6670200110.1097/00003086-200112000-00007

3. 

E InghamJ FisherThe role of macrophages in osteolysis of total joint replacementBiomaterials2612711286200510.1016/j.biomaterials.2004.04.03515475057

4. 

G HoltC MurnaghanJ ReillyRM MeekThe biology of aseptic osteolysisClin Orthop Relat Res460240252200717620815

5. 

F von KnochC WedemeyerA HeckeleiPromotion of bone formation by simvastatin in polyethylene particle-induced osteolysisBiomaterials2657835789200515869791

6. 

X PengK TaoT ChengJ ZhuX ZhangEfficient inhibition of wear debris-induced inflammation by locally delivered siRNABiochem Biophys Res Commun377532537200810.1016/j.bbrc.2008.10.02618930023

7. 

M TakagiYT KonttinenS SantavirtaExtracellular matrix metalloproteinases around loose total hip prosthesesActa Orthop Scand65281286199410.3109/174536794089954548042479

8. 

B NawrockiM PoletteH BurletP BirembautJJ AdnetExpression of gelatinase A and its activator MT1-MMP in the inflammatory periprosthetic response to polyethyleneJ Bone Miner Res14288294199910.1359/jbmr.1999.14.2.2889933484

9. 

I TakeiM TakagiS SantavirtaMatrix metalloproteinases and tissue inhibitors of metalloproteinases in joint fluid of the patients with loose artificial hip jointsJ Biomed Mater Res45175183199910.1002/(SICI)1097-4636(19990605)45:3%3C175::AID-JBM3%3E3.0.CO;2-910397973

10. 

S WagnerH GollwitzerD WernickeR LangerKA SiebenrockW HofstetterInterface membrane fibroblasts around aseptically loosened endoprostheses express MMP-13J Orthop Res26143152200810.1002/jor.2049417853491

11. 

P ReponenC SahlbergC MunautI ThesleffK TryggvasonHigh expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse developmentJ Cell Biol12410911102199410.1083/jcb.124.6.10918132709

12. 

CH TsaiYJ ChenFM HuangYF SuYC ChangThe upregulation of matrix metalloproteinase-9 in inflamed human dental pulpsJ Endod31860862200510.1097/01.don.0000164851.55389.4e16306818

13. 

AL WucherpfennigYP LiWG Stetler-StevensonAE RosenbergP StashenkoExpression of 92 kD type IV collagenase/gelatinase B in human osteoclastsJ Bone Miner Res9549556199410.1002/jbmr.56500904158030443

14. 

PT De JongW TigchelaarCJ Van NoordenHM Van der VisPolyethylene wear particles do not induce inflammation or gelatinase (MMP-2 and MMP-9) activity in fibrous tissue interfaces of loosening total hip arthroplastiesActa Histochem113556563201120656340

15. 

C ZhangTT TangWP RenXL ZhangKR DaiInhibiting wear particle-induced osteolysis with doxycyclineActa Pharmacol Sin2816031610200710.1111/j.1745-7254.2007.00638.x17883947

16. 

Y GuHM LeeT SorsaSR SimonLM GolubDoxycycline inhibits mononuclear cell-mediated connective tissue breakdownFEMS Immunol Med Microbiol58218225201010.1111/j.1574-695X.2009.00625.x19909341

17. 

D GengY XuH YangProtection against titanium particle induced osteolysis by cannabinoid receptor 2 selective antagonistBiomaterials3119962000201010.1016/j.biomaterials.2009.11.06920004468

18. 

CA HoldingDM FindlayR StamenkovThe correlation of RANK, RANKL and TNFalpha expression with bone loss volume and polyethylene wear debris around hip implantsBiomaterials2752125219200616806459

19. 

C WedemeyerC NeuerburgA PfeifferPolyethylene particle-induced bone resorption in alpha-calcitonin gene-related peptide-deficient miceJ Bone Miner Res2210111019200710.1359/jbmr.07040817419680

20. 

SY YangB WuL MaytonProtective effects of IL-1Ra or vIL-10 gene transfer on a murine model of wear debris-induced osteolysisGene Ther11483491200410.1038/sj.gt.330219214724688

21. 

W RenSY YangPH WooleyA novel murine model of orthopaedic wear-debris associated osteolysisScand J Rheumatol33349357200410.1080/0300974041000594415513686

22. 

X MaoX PanS ZhaoX PengT ChengX ZhangProtection against titanium particle-induced inflammatory osteolysis by the proteasome inhibitor bortezomib in vivoInflammation3513781391201210.1007/s10753-012-9451-822391745

23. 

PH WooleyR MorrenJ AndaryInflammatory responses to orthopaedic biomaterials in the murine air pouchBiomaterials23517526200210.1016/S0142-9612(01)00134-X11761173

24. 

JD SamsJC MilbrandtJM FroelichAD RainvilleDG AllanHospital outcome after emergent vs elective revision total hip arthroplastyJ Arthroplasty25826828201010.1016/j.arth.2010.01.09720378305

25. 

NJ EpsteinBA WarmeJ SpanogleInterleukin-1 modulates periprosthetic tissue formation in an intramedullary model of particle-induced inflammationJ Orthop Res23501510200510.1016/j.orthres.2004.10.00415885468

26. 

J WaddellKP PritzkerEL BoyntonIncreased cytokine secretion in patients with failed implants compared with patients with primary implantsClin Orthop Relat Res434170176200510.1097/01.blo.0000155079.29604.d415864048

27. 

RM AtkinsVG LangkamerMJ PerryCJ ElsonCM CollinsBone-membrane interface in aseptic loosening of total joint arthroplastiesJ Arthroplasty12461464199710.1016/S0883-5403(97)90203-59195323

28. 

SB GoodmanP HuieY SongCellular profile and cytokine production at prosthetic interfaces. Study of tissues retrieved from revised hip and knee replacementsJ Bone Joint Surg Br80531539199810.1302/0301-620X.80B3.81589619952

29. 

SR GoldringAL SchillerM RoelkeCM RourkeDA O’NeilWH HarrisThe synovial-like membrane at the bone-cement interface in loose total hip replacements and its proposed role in bone lysisJ Bone Joint Surg Am6557558419836304106

30. 

KJ KimHE RubashSC WilsonJA D’AntonioEJ McClainA histologic and biochemical comparison of the interface tissues in cementless and cemented hip prosthesesClin Orthop Relat Res28714215219938448933

31. 

GF MaA AliN VerzijlIncreased collagen degradation around loosened total hip replacement implantsArthritis Rheum5429282933200610.1002/art.2206416948130

32. 

Y YokohamaT MatsumotoM HirakawaProduction of matrix metalloproteinases at the bone-implant interface in loose total hip replacementsLab Invest7389991119958558853

33. 

F VelardD Laurent-MaquinJ BrauxThe effect of zinc on hydroxyapatite-mediated activation of human polymorphonuclear neutrophils and bone implant-associated acute inflammationBiomaterials3120012009201010.1016/j.biomaterials.2009.11.066

34. 

M TakagiY TamakiH HasegawaToll-like receptors in the interface membrane around loosening total hip replacement implantsJ Biomed Mater Res A8110171026200710.1002/jbm.a.3123517415764

35. 

P LaquerriereA Grandjean-LaquerriereS Addadi-RebbahMMP-2, MMP-9 and their inhibitors TIMP-2 and TIMP-1 production by human monocytes in vitro in the presence of different forms of hydroxyapatite particlesBiomaterials2525152524200410.1016/j.biomaterials.2003.09.03414751736

36. 

N TakiJM TatroR LoweVM GoldbergEM GreenfieldComparison of the roles of IL-1, IL-6, and TNFalpha in cell culture and murine models of aseptic looseningBone4012761283200710.1016/j.bone.2006.12.05317236833

37. 

TJ FedericiThe non-antibiotic properties of tetracyclines: clinical potential in ophthalmic diseasePharmacol Res64614623201110.1016/j.phrs.2011.06.01321843641

38. 

AC LauTT DuongS ItoGJ WilsonRS YeungInhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki diseaseClin Exp Immunol157300309200910.1111/j.1365-2249.2009.03949.x19604270

39. 

S SamtaniJ AmaralMM CamposRN FarissSP BecerraDoxycycline-mediated inhibition of choroidal neovascularizationInvest Ophthalmol Vis Sci5050985106200910.1167/iovs.08-317419516001

40. 

WP RenDC MarkelR ZhangAssociation between UHMWPE particle-induced inflammatory osteoclastogenesis and expression of RANKL, VEGF, and Flt-1 in vivoBiomaterials2751615169200610.1016/j.biomaterials.2006.04.00416814378

41. 

JJ HyunHJ ChunB KeumEffect of omeprazole on the expression of transcription factors in osteoclasts and osteoblastsInt J Mol Med26877883201021042782

42. 

W SriarjK AokiK OhyaY TakagiH ShimokawaBovine dentine organic matrix down-regulates osteoclast activityJ Bone Miner Metab27315323200910.1007/s00774-009-0063-919296049

43. 

SK TatJP PelletierF MineauJ CaronJ Martel-PelletierStrontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblastsBone49559567201110.1016/j.bone.2011.06.00521700005

44. 

MG ChoiHS KohD KluessEffects of titanium particle size on osteoblast functions in vitro and in vivoProc Natl Acad Sci USA10245784583200510.1073/pnas.050069310215755807

45. 

S JuradoN Garcia-GiraltA Diez-PerezEffect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblastsJ Cell Biochem110304310201020225238

46. 

K SundaramR NishimuraJ SennRF YoussefSD LondonSV ReddyRANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiationExp Cell Res313168178200710.1016/j.yexcr.2006.10.00117084841

47. 

X MaoX PanT ChengX ZhangTherapeutic potential of the proteasome inhibitor bortezomib on titanium particle-induced inflammation in a murine modelInflammation35905912201210.1007/s10753-011-9392-721965047

Related Articles

Journal Cover

December 2012
Volume 30 Issue 6

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen D, Zhang X, Guo Y, Shi S, Mao X, Pan X and Cheng T: MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model. Int J Mol Med 30: 1417-1423, 2012
APA
Chen, D., Zhang, X., Guo, Y., Shi, S., Mao, X., Pan, X., & Cheng, T. (2012). MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model. International Journal of Molecular Medicine, 30, 1417-1423. https://doi.org/10.3892/ijmm.2012.1145
MLA
Chen, D., Zhang, X., Guo, Y., Shi, S., Mao, X., Pan, X., Cheng, T."MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model". International Journal of Molecular Medicine 30.6 (2012): 1417-1423.
Chicago
Chen, D., Zhang, X., Guo, Y., Shi, S., Mao, X., Pan, X., Cheng, T."MMP-9 inhibition suppresses wear debris-induced inflammatory osteolysis through downregulation of RANK/RANKL in a murine osteolysis model". International Journal of Molecular Medicine 30, no. 6 (2012): 1417-1423. https://doi.org/10.3892/ijmm.2012.1145